The first coronavirus vaccine trial began Monday in Seattle when four volunteers received a version of a vaccine.
and researchers will first study its safety. If after several weeks it appears to be safe, another round of testing will begin to see whether it stimulates their immune system to make antibodies against the virus. It was one of three groups that received funding for the effort Jan. 23 from the CEPI.” vaccines against MERS for several years and had a version showing results in animal studies. It got funding from CEPI and retooled its research for SARS-CoV-2 in February.
after the genetic sequence was published by the Chinese. The company plans to begin human trials in April.This German-based company was in the news last week after reports surfaced President Donald Trump suggested the U.S. might buy access to its vaccines. CureVac, which was mainly working on anti-cancer vaccines, uses messenger RNA to make vaccines. It signed a development agreement with CEPI on Jan. 31 to work on SARS-CoV-2.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
'Race against the clock': Scientists testing if existing drugs can fight novel coronavirus right nowDozens of already-existing drugs may be able to treat the novel coronavirus.
続きを読む »
For better or worse, coronavirus tests couples forced to share home officesBefore coronavirus shut his office, Scott Ford worked with his phone in one hand...
続きを読む »
Mass move to work from home in coronavirus crisis creates opening for hackers: cyber expertsAs people disperse to their homes to work and study because of the coronavirus p...
続きを読む »
Police implement sweeping policy changes to prepare for coronavirus spreadPolice departments are adjusting the way they work in the age of coronavirus.
続きを読む »
Here are 3 drugs in development to fight coronavirus, 2 vaccines and one 'passive' vaccineMany companies are working on vaccines, but these are the three that experts say are closest to being tested, approved and available to the U.S. public.
続きを読む »